Literature DB >> 10835520

Informed evaluation of pathology residency programs.

R F Yorke1.   

Abstract

OBJECTIVES: To identify resources and summarize important issues in anatomic and clinical pathology training and to assist the pathology resident candidate in evaluating potential training programs. DATA SOURCES: Published guides for medical residency applicants, recent literature discussing pathology education, and World Wide Web sites. STUDY SELECTION: Resources perceived by the author as valuable for the pathology resident candidate. DATA EXTRACTION: Key issues in pathology education are identified. DATA SYNTHESIS: Issues are discussed from the perspective of a pathology resident candidate, and resources for further information are provided.
CONCLUSIONS: The pathology residency candidate faces unique challenges in the residency search process because of the breadth of pathology training and the limited exposure to the practice of pathology in medical school. General guides for residency applicants include little discussion of pathology-specific issues. Recent literature discussing pathology education is fragmented but provides invaluable insights for resident candidates. This review seeks to identify a wide variety of issues and resources as a starting point for evaluating potential training programs.

Mesh:

Year:  2000        PMID: 10835520     DOI: 10.5858/2000-124-0853-IEOPRP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  2 in total

1.  Histopathology training in Europe: a lesson for other specialties?

Authors:  Dirk J Ruiter; Borghild Roald; James Underwood; Jaime Prat
Journal:  Virchows Arch       Date:  2003-12-02       Impact factor: 4.064

2.  Visual-spatial dimension integration in digital pathology education enhances anatomical pathology learning.

Authors:  Ken Lee Wan; Arkendu Sen; Lakshmi Selvaratnam; Mohd Imran Mohd Naing; Joon Joon Khoo; Pathmanathan Rajadurai
Journal:  BMC Med Educ       Date:  2022-07-30       Impact factor: 3.263

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.